Table 2.
List of early postpartum oocyte-specific DMRs overlapping imprinted gene bodies.
| Gene | Probe location | Methylation level (%) | Overlapping CpG island | Overlapping exon | ||
|---|---|---|---|---|---|---|
| Epp | Mpp | CH | ||||
| DIRAS3 | Chr3:77572944–77582220 | 68.91 | 54.76 | 54.79 | + | + |
| SGCE/PEG10 | Chr4:11911539–11912583 | 67.52 | 35.40 | 33.34 | + | + |
| MEST | Chr4:95066705–95067686 | 64.18* | 34.63* | 45.52* | + | + |
| MEST | Chr4:95067710–95072935 | 74.69 | 61.76 | 56.91 | − | + |
| NAP1L5 | Chr6:37509075–37510923 | 71.47 | 45.96 | 43.66 | − | + |
| IGF2R | Chr9:97639143–97641473 | 74.90 | 84.92 | 89.40 | − | − |
| IGF2R | Chr9:97654566–97658868 | 83.48 | 71.02 | 68.94 | − | + |
| IGF2R | Chr9:97658884–97661928 | 68.46 | 40.84 | 39.89 | − | − |
| IGF2R | Chr9:97664415–97669428 | 79.96 | 56.80 | 54.21 | + | + |
| IGF2R | Chr9:97669459–97672435 | 76.73 | 58.01 | 55.43 | − | − |
| IGF2R | Chr9:97677102–97678968 | 75.23 | 50.88 | 47.24 | − | − |
| IGF2R | Chr9:97683111–97685609 | 82.86 | 62.47 | 68.34 | − | + |
| IGF2R | Chr9:97696872–97698360 | 84.14 | 67.99 | 64.95 | − | + |
| IGF2R | Chr9:97698361–97700386 | 82.20 | 68.84 | 64.51 | − | − |
| IGF2R | Chr9:97723665–97725285 | 88.60 | 76.54 | 75.85 | − | + |
| IGF2R | Chr9:97729941–97731789 | 85.35 | 75.30 | 71.92 | − | − |
| IGF2R | Chr9:97731832–97733485 | 73.48 | 52.29 | 51.05 | + | + |
| GNAS | Chr13:58017810–58022193 | 60.92 | 49.16 | 50.34 | − | + |
| GNAS | Chr13:58028217–58033182 | 73.78 | 41.85 | 42.32 | + | + |
| GNAS | Chr13:58033183–58034298 | 69.10 | 39.73 | 34.80 | + | − |
| GNAS | Chr13:58034299–58035180 | 70.20 | 46.54 | 41.68 | + | − |
| GNAS | Chr13:58035201–58036679 | 73.48 | 55.78 | 49.28 | + | − |
| GNAS | Chr13:58036729–58037912 | 63.27 | 34.61 | 28.17 | + | − |
| GNAS | Chr13:58037929–58040073 | 76.55 | 46.12 | 45.39 | + | − |
| GNAS | Chr13:58040227–58046005 | 64.63 | 53.93 | 52.90 | − | − |
| GNAS | Chr13:58047147–58048143 | 19.79 | 37.44 | 30.89 | + | + |
| NNAT | Chr13:67118471–67119734 | 77.60 | 40.88 | 46.39 | − | + |
| NNAT | Chr13:67119735–67122534 | 73.18 | 60.18 | 60.95 | − | + |
| SNRPN | Chr21:13703–24837 | 70.60 | 37.27 | 44.83 | − | + |
| SNRPN | Chr21:24838–26023 | 66.22 | 34.92 | 32.17 | + | + |
| MAGEL2 | Chr21:784775–797175 | 47.18 | 31.21 | 27.70 | − | + |
| BEGAIN | Chr21:67073406–67074663 | 53.60 | 76.84 | 85.63 | + | + |
| BEGAIN | Chr21:67074664–67076413 | 50.29 | 67.12 | 68.79 | − | + |
| BEGAIN | Chr21:67076414–67079286 | 41.83 | 66.02 | 63.67 | − | + |
| BEGAIN | Chr21:67082421–67084236 | 50.61 | 65.72 | 72.34 | − | + |
| BEGAIN | Chr21:67084286–67085973 | 39.77 | 53.52 | 54.18 | + | − |
| BEGAIN | Chr21:67089429–67092594 | 77.28 | 61.97 | 60.42 | − | − |
| BEGAIN | Chr21:67092595–67095173 | 64.69 | 29.43 | 24.94 | + | − |
| BEGAIN | Chr21:67095174–67098689 | 61.99 | 22.32 | 22.41 | + | − |
| BEGAIN | Chr21:67098706–67099431 | 53.50 | 4.28 | 3.32 | + | + |
| RTL1 | Chr21:67426306–67427887 | 49.26 | 61.78 | 67.91 | + | + |
| RTL1 | Chr21:67427910–67429035 | 66.64 | 94.10 | 91.23 | + | + |
| RTL1 | Chr21:67429048–67430254 | 54.79 | 90.02 | 89.27 | + | + |
| RTL1 | Chr21:67430264–67432092 | 65.54 | 82.26 | 88.41 | + | + |
| TSSC4 | Chr29:49836440–49837857 | 74.90 | 87.95 | 87.48 | − | + |
| ASCL2 | Chr29:49957329–49959108 | 60.98 | 46.72 | 45.26 | + | + |
| IGF2 | Chr29:50045707–50047790 | 28.20 | 39.23 | 39.61 | − | + |
| IGF2 | Chr29:50061341–50062955 | 43.98 | 61.46 | 64.07 | + | + |
| IGF2 | Chr29:50064682–50065982 | 43.86 | 80.23 | 80.77 | + | + |
*Denotes a single DMR differentially methylated in all conditions. + and − denote presence or absence of overlap, respectively.